» Articles » PMID: 7770771

Deregulated T Cell Activation and Autoimmunity in Mice Lacking Interleukin-2 Receptor Beta

Overview
Journal Science
Specialty Science
Date 1995 Jun 9
PMID 7770771
Citations 296
Authors
Affiliations
Soon will be listed here.
Abstract

In mice lacking the interleukin-2 receptor beta chain (IL-2R beta), T cells were shown to be spontaneously activated, resulting in exhaustive differentiation of B cells into plasma cells and the appearance of high serum concentrations of immunoglobulins G1 and E as well as autoantibodies that cause hemolytic anemia. Marked infiltrative granulocytopoiesis was also apparent, and the animals died after about 12 weeks. Depletion of CD4+ T cells in mutant mice rescued B cells without reversion of granulocyte abnormalities. T cells did not proliferate in response to polyclonal activators, nor could antigen-specific immune responses be elicited. Thus, IL-2R beta is required to keep the activation programs of T cells under control, to maintain homeostasis, and to prevent autoimmunity.

Citing Articles

Based on the immune system: the role of the IL-2 family in pancreatic disease.

Zhu Y, Lu Z, Wang Z, Liu J, Ning K Front Immunol. 2025; 16:1480496.

PMID: 39958351 PMC: 11825815. DOI: 10.3389/fimmu.2025.1480496.


Hypothetical proteins of chicken-isolated Limosilactobacillus reuteri subjected to in silico analyses induce IL-2 and IL-10.

Adejumo I Genes Nutr. 2024; 19(1):21.

PMID: 39425027 PMC: 11490116. DOI: 10.1186/s12263-024-00755-4.


Nonclinical evaluations of deucravacitinib and Janus kinase inhibitors in homeostatic and inflammatory pathways.

Johnson B, Cheng L, Koenitzer J, Catlett I, Schafer P Front Immunol. 2024; 15:1437512.

PMID: 39403378 PMC: 11472182. DOI: 10.3389/fimmu.2024.1437512.


IL-2 based cancer immunotherapies: an evolving paradigm.

Rokade S, Damani A, Oft M, Emmerich J Front Immunol. 2024; 15:1433989.

PMID: 39114660 PMC: 11303236. DOI: 10.3389/fimmu.2024.1433989.


Elevated levels of IL-12/IL-23p40 in Nova Scotia Duck Tolling Retrievers with autoimmune disease and lymphoma.

Nilsson M, Kozyrev S, Saellstrom S, Johansson S, Andersson G, Lindblad-Toh K Sci Rep. 2024; 14(1):11624.

PMID: 38773194 PMC: 11109178. DOI: 10.1038/s41598-024-62265-y.